Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen receives patent coverage for GRB2 cancer target

April 9, 1997

No Comments

NIH licenses PTC gene for cancer diagnosis and therapy

April 9, 1997

No Comments

Nigella sativa plant extract exerts antiangiogenic activity

April 8, 1997

No Comments

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

April 8, 1997

No Comments

Eagle licenses biotin technology from University of Washington

April 8, 1997

No Comments

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

April 8, 1997

No Comments

University of Texas/Regeneron research finding covered under U.S. patent

April 7, 1997

No Comments

Onyx expands clinical trials of ONYX-015

April 7, 1997

No Comments

Yewtaxan cleared for marketing in The Netherlands

April 7, 1997

No Comments

Antiangiogenic antibody from Ixsys enters clinical trials

April 4, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

Sugen receives patent coverage for GRB2 cancer target

NIH licenses PTC gene for cancer diagnosis and therapy

Nigella sativa plant extract exerts antiangiogenic activity

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

Eagle licenses biotin technology from University of Washington

Taiho claims nitroimidazoles with antiangiogenic and contrast-enhancing effects

University of Texas/Regeneron research finding covered under U.S. patent

Onyx expands clinical trials of ONYX-015

Yewtaxan cleared for marketing in The Netherlands

Antiangiogenic antibody from Ixsys enters clinical trials

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Cancer RSS

Cancer
RSS